Area of research
Radiology, Nuclear Medicine and Imaging · Immunology
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, Toxin Mechanisms and Immunotoxins, Glycosylation and Glycoproteins Research, and Herpesvirus Infections and Treatments.
Development and Validation of an LC–MS-Based Quantification Assay for New Therapeutic Antibodies: Application to a Novel Therapy against Herpes Simplex Virus
Highly efficient destruction of squamous carcinoma cells of the head and neck by photochemical internalization of Ranpirnase.
PubMed 2017cited by 2position: middle
Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model
A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells
High treatment efficacy by dual targeting of Burkitt’s lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab
Genetic delivery of an immuno<scp>RN</scp>ase by an oncolytic adenovirus enhances anticancer activity
A fusogenic dengue virus-derived peptide enhances antitumor efficacy of an antibody-ribonuclease fusion protein targeting the EGF receptor
An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo
Antibody‐Targeted Drugs: From Chemical Immunoconjugates to Recombinant Fusion Proteins
Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential